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Background: Chronic lower airway inﬂammation is considered to be a major cause of pathogenesis and
disease progression in chronic obstructive pulmonary disease (COPD). Moraxella catarrhalis is a COPD-
associated pathogen causing exacerbations and bacterial colonization in the lower airways of patients,
which may contribute to chronic inﬂammation. Increasing evidence suggests that the epidermal growth
factor receptor (EGFR) modulates inﬂammatory processes in the human airways. The goal of this study
was to investigate the role of EGFR in the M. catarrhalis-induced pro-inﬂammatory immune response
in airway epithelial cells.
Methods: The effects of inhibition and gene silencing of EGFR on M. catarrhalis-dependent pro-
inﬂammatory cytokine expression in human primary bronchial epithelial cells (NHBEs), as well as the
pulmonary epithelial cell lines BEAS-2B and A549 were analyzed. We also assessed the involvement of
EGFR-dependent ERK and NF-jB signaling pathways.
Results: The M. catarrhalis-induced pro-inﬂammatory immune response depends, at least in part, on the
phosphorylation and activation of the EGF receptor. Interaction of M. catarrhalis with EGFR increases the
secretion of pro-inﬂammatory cytokines, which is mediated via ERK and NF-jB activation.
Conclusion: The interaction between M. catarrhalis and EGFR increases airway inﬂammation caused by
this pathogen. Our data suggest that the inhibition of EGFR signaling in COPD could be an interesting
target for reducing M. catarrhalis-induced airway inﬂammation.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction expression of pro-inﬂammatory cytokines and chemokines (e.g.,1.1. EGFR expression in the airways in COPD
Chronic obstructive pulmonary disease (COPD) is associated
with chronic neutrophilic inﬂammation of the lower airways [1].
The expression of epidermal growth factor receptor (EGFR) is
increased in the airway epithelium of COPD patients [2]. EGFR
activation is involved in repair and regeneration processes in air-
way epithelial cells, but has also been shown to be linked to thevia activation of MAPK pathways [3,4]). In particular, increased
secretion of the chemokine interleukin (IL) 8 has a considerable
impact on neutrophil recruitment in the airways and pulmonary
tissues [4–8]. Chronic inﬂammation with the involvement of neu-
trophils leads to airway remodeling and progressing airﬂow limita-
tion and so is believed to play a major role in the pathogenesis and
progression of COPD [1,9]. However, current pharmacological
therapies only have limited inﬂuence on neutrophil recruitment
and chronic inﬂammation.
1.2. The role of bacterial infection in COPD
As the ﬁrst line of pathogen defense in the human lung, the epi-
thelium of the lower airways is equipped with multiple mecha-
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respiratory tract is considered to be sterile and bacteria can only be
detected in around 4% of these individuals [10]. Due to chronic
inﬂammation, mucus retention, and hypersecretion, defense
mechanisms in the lower airways of COPD patients deteriorate.
In particular, the function of the mucociliary clearance as a
centrally important defense mechanism for removing invading
pathogens from the lower airways is restricted by the chronic
inﬂammatory process, leading to bacterial colonization of the
lower airways [11]. The three most frequently detected bacterial
pathogens in both stable and exacerbated COPD are Haemophilus
inﬂuenzae, Moraxella catarrhalis, and Streptococcus pneumoniae
[10]. M. catarrhalis is responsible for 10–15% of exacerbations
[12], colonizes in up to 32% of COPD patients [13,14], and is
believed to play an important role in maintaining chronic
inﬂammation and promoting disease progression [12].
1.3. Interaction of EGFR and pathogens
M. catarrhalis induces a pro-inﬂammatory immune response,
which is dependent on mitogen activated protein kinase (MAPK)
extracellular-signal regulated kinase (ERK), and activation of the
transcription factor nuclear factor jB (NF-jB) [15]. Interestingly,
EGFR is an important receptor that is known to activate the cells
via ERK signaling pathways [3]. Several authors have reported
the activation of EGFR by bacterial or viral pathogens [16–18]. In
vitro studies have also indicated regulatory functions of EGFR on
pro-inﬂammatory IL8 secretion via ERK signaling in infected air-
way epithelial cells [18,19]. We hypothesized that M. catarrhalis
might induce a pro-inﬂammatory immune response by activation
of EGFR in airway epithelium.
We therefore investigated the role of EGFR in theM. catarrhalis-
induced pro-inﬂammatory immune response in airway epithelial
cells. In addition, the possible involvement of dependent ERK and
NF-jB signaling pathways was evaluated.2. Materials and methods
2.1. Cell lines
Normal human bronchial epithelial cells (NHBEs) from healthy
volunteers were obtained from Lonza (Cologne, Germany). Human
bronchial epithelial cell line BEAS-2B was kindly donated by C.
Harris (National Institutes of Health, Bethesda, MD, USA). A549
epithelial cells (type II alveolar lung epithelium cells; ATCC
CCL85) were obtained from ATCC.
The NF-jB-dependent reporter cell line, A549 6Btkluc, was
kindly given to us by R. Newton (University of Warwick, Coventry,
UK). These cells contain a stably integrated plasmid with three tan-
dem repeats of the sequence 50-AGCTTACAAGGGATTTCCGCTGGGG
ACTTTCCAGGGA-30, which contains two copies of the decameric
NF-jB binding site upstream of a minimal thymidine kinase
promoter (-105–51) driving a luciferase gene 27.
All cell lines were cultured at 37 C in a humidiﬁed atmosphere
with 5% CO2. Cells were grown to conﬂuence (over 100%) in 75 cm2
ﬂasks and then were cultured in multi-well plates (both Falcon and
Corning Star). Twelve hours before the experiment, cells were
grown in a medium without antibiotic supplements.
2.2. M. catarrhalis strains
M. catarrhalis wild type strain O35E (serotype A) was kindly
provided by Eric Hansen (University of Texas Southwestern
Medical Center, Dallas, TX, USA). M. catarrhalis strain 25238 was
purchased from ATCC. Strains were grown overnight at 37 C in ahumidiﬁed atmosphere with 5% CO2 on Columbia agar with 5%
sheep blood (BD Diagnostics, Germany). For infection experiments,
single colonies of bacterial overnight cultures were expanded by
re-suspension in BHI broth and incubation at 37 C for 2 h, har-
vested by centrifugation, re-suspended in cell culture medium
without antibiotics, and adjusted to an optical density (OD) at
405 nm of 0.3 [1  108 colony-forming units (cfu)/ml] and used
for infecting the cells at the indicated cfu/ml or multiplicity of
infection (MOI).
2.3. IL8 and IL6 ELISA
Conﬂuent BEAS-2B cells were stimulated as indicated. IL8 or IL6
secreted by the cells were evaluated with a commercially available
ELISA kit according to the manufacturer’s protocol (IL8 ELISA, BD
Biosciences; IL6 ELISA, Ebioscience).
2.4. RT-PCR analysis
RNA was extracted using the RNeasy Mini kit (Qiagen, Hilden,
Germany), according to the manufacturer’s instructions. All prim-
ers were purchased from TIB MOLBIOL (Berlin, Germany). PCR
products were analyzed on 1.5% agarose gels, stained with ethi-
dium bromide, and subsequently visualized. To conﬁrm equal
loading, PCR for glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was performed in parallel.
2.5. Western Blot analysis
Cells were lysed in buffer-containing Triton X-100, separated by
SDS–PAGE, and blotted on Hybond-ECL membranes (Amersham
Biosciences). Speciﬁc antibodies, as well as corresponding second-
ary antibodies labeled with IRDye (Li-COR Biosciences), were used
for immunodetection of target proteins. Actin or Akt were mea-
sured simultaneously on the same membrane to conﬁrm equal
protein loading. Membranes were scanned and quantiﬁed with
two different channels (channel 800, green; channel 700, red;
Odyssey Infrared Imaging System; Li-COR Biosciences). The
intensities of the green and the red channels were quantiﬁed by
integrated image analysis.
2.6. RNA-mediated interference
Control non-silencing siRNA (siRNA control, MWG Biotech AG,
Germany) and siRNA targeting EGFR mRNA (siRNA EGFR silencer
select validated, Ambion) were used. A549 or BEAS-2B cells were
transfected with the Amaxa Nucleofector kit (Amaxa) according to
the manufacturer’s protocol (Nucleofector Solution V; Nucleofector
program G-16) with EGFR siRNA at a dose of 2 lg (25 nM) per
1  106 cells as described previously [20].
2.7. Chromatin immunoprecipitation (ChIP)
Chromatin immunoprecipitation was carried out as described
previously [15]. Brieﬂy, cells were lysed in ChIP radio-immunopre-
cipitation assay (RIPA) buffer and chromatin was sheared by
sonication. All antibodies were purchased from Santa Cruz
Biotechnology. Immunoprecipitations from soluble chromatin
were carried out overnight at 4 C. Immune complexes were col-
lected with protein A/G agarose (Santa Cruz Biotechnology) for
60 min and washed thoroughly with RIPA buffer and high-salt buf-
fer. We extracted immune complexes in elution buffer which were
then digested with RNase for 30 min at 37 C. After proteinase K
digestion for 6 h at 37 C and 6 h at 65 C, DNA was extracted with
a PCR puriﬁcation kit (Qiagen, Hilden, Germany). IL8 promoter
DNA was ampliﬁed by PCR using Hot Star Taq (Qiagen) DNA
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phoresis and detected by ethidium bromide staining. Equal
amounts of input DNA were controlled by gel electrophoresis.
2.8. Inhibitors
EGFR tyrosine kinase inhibitor AG1478, ERK inhibitor U0126,
and IKK-NBD peptide (inhibiting NF-jB activation) were purchased
from Calbiochem (Merck, Bad Soden, Germany).
2.9. Luciferase activity
Luciferase activity was measured using a luciferase reporter
gene assay (Promega, Mannheim, Germany). All other chemicals
used in the study were of analytical grade and obtained from
commercial sources.
2.10. Statistical analysis
Data are shown as means ± s.e.m. of at least three independent
experiments. A one-way ANOVA followed by a Newman–Keuls
post-test was used to compare means of two samples. Statistical
signiﬁcance was considered to be reached for p < 0.05, as indicated
by asterisks.
3. Results
3.1. M. catarrhalis activates EGFR in pulmonary epithelial cells
Firstly, we analyzed the EGFR expression in primary human
bronchial epithelial cells (NHBE), as well as in the pulmonary
epithelial cell lines BEAS-2B and A549 via Western Blot and RT-
PCR. As shown in Fig. 1A and B in all epithelial cells EGFR expres-
sion was conﬁrmed.
Upon activation of EGFR, phosphorylated receptor tyrosine res-
idues serve as docking sites of a range of proteins, whose recruit-
ment activates downstream signaling pathways [3]. In a Western
Blot analysis we demonstrated that M. catarrhalis causes a consid-
erable phosphorylation of EGFR tyrosine residues and that this
effect increases with time (Fig. 1C). Inhibition of EGFR withFig. 1. (A) Immunoblot analysis of EGFR in cell lysates of NHBE, BEAS-2B, and A549 cells.
cell lysates of NHBE, BEAS-2B, and A549 cells. (C) BEAS-2B cells were infected withM. ca
stimulation control. Cell lysates were analyzed for phosphorylated EGFR (pEGFR) by W
pretreated as indicated with EGFR inhibitor AG1478 2 h before infection with M. cata
(pEGFR) by Western Blot. EGF (100 ng/ml) was used as a stimulation control. Detectionselective EGFR tyrosine kinase inhibitor AG1478 led to a signiﬁcant
decrease in M. catarrhalis-induced EGFR phosphorylation (Fig. 1D).3.2. Inhibition or knock-down of EGFR decreases M. catarrhalis-
induced IL8
In a next step, we were able to demonstrate that inhibition of
EGFR with AG1478 causes a signiﬁcant decrease in M. catarrhalis
induced IL8 and IL6 secretion in NHBE as assessed by an ELISA
essay (Fig. 2A and B). These data suggested a considerable impact
of EGFR on the pro-inﬂammatory immune response towards M.
catarrhalis in the human airways.
To conﬁrm the regulatory function of EGFR for the M. catarrhal-
is-induced immune response in pulmonary epithelial cells, we per-
formed RNA-mediated interference experiments. The viability of
NHBEs was much lower during the gene-knockout procedure,
because of the transfection reagents (data not shown). Therefore,
we used the pulmonary epithelial cell line BEAS-2B. Firstly, we
conﬁrmed the EGFR-dependent M. catarrhalis-induced IL8 secre-
tion in BEAS-2B cells, which again was reduced after pretreatment
of the cells with the selective EGFR inhibitor AG1478, as assessed
by RT PCR (Fig. 2C) and ELISA (Fig. 2D). Knock-down of EGFR
expression via RNA interference was conﬁrmed by RT PCR
(Fig. 2E) and revealed a signiﬁcant decrease in IL8 secretion after
infection with M. catarrhalis (Fig. 2F).3.3. The EGFR-dependent IL8 response is mediated via ERK and NF-jB
signaling
In a next step we analyzed speciﬁc pathways for their involve-
ment in the M. catarrhalis-induced and EGFR-dependent cytokine
release. As shown in Fig. 3A, in pulmonary epithelial cells infected
withM. catarrhalis, inhibition of ERK by U0126 resulted in a signif-
icant decrease in IL8 secretion (Fig. 3A). Involvement of ERK phos-
phorylation was further conﬁrmed by Western Blot. Our results
revealed that the infection of the cells with M. catarrhalis causes
phosphorylation of ERK and that this effect could be reduced by
the inhibition of EGFR (Fig. 3B).
Moreover, we found that the activation of transcription factor
NF-jB was also involved in the EGFR-dependent immune responseProtein kinase Akt served as a loading control. (B) RT-PCR analysis of EGFR mRNA in
tarrhalis (107 cfu/ml) for the periods of time indicated. EGF (25 ng/ml) was used as a
estern Blot. Detection of EGFR served as a loading control. (D) BEAS-2B cells were
rrhalis (108 cfu/ml). After 2 h, cell lysates were analyzed for phosphorylated EGFR
of Akt served as a loading control.
Fig. 2. (A/B) Conﬂuent NHBE cells were pretreated with the doses of EGFR inhibitor AG1478 indicated 1 h before infection with M. catarrhalis (MOI of 0.1). After 24 h,
concentrations of IL8 (A) or IL6 (B) were assessed in the supernatants by ELISA. (C) Conﬂuent BEAS-2B cells were pretreated as indicated with AG1478 (30 lM) 2 h before
infection with M. catarrhalis (107 cfu/ml). After 12 h IL8 mRNA was detected by RT-PCR. (D) Conﬂuent BEAS-2B cells were pretreated as indicated with AG1478 (3 lM) 2 h
before infection withM. catarrhalis (107 cfu/ml). After 16 h, IL8 was assessed in the supernatants by ELISA. (E) BEAS-2B cells were transfected with control siRNA (csi) or two
different types of EGFR siRNA (siEGFR#1; siEGFR#2). After 48 h, EGFR silencing was conﬁrmed by RT-PCR. (F) 48 h after transfection, cells were infected with M. catarrhalis
(MOI 0.1). After 24 h, IL8 concentration in supernatants was assessed by ELISA. ⁄p < 0.05 in one-way ANOVA.
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inhibitory-jB-kinase NF-jB-essential-modulator-binding-domain
peptide (IKK-NBD) also led to a decrease in M. catarrhalis-induced
cytokine secretion. In addition, NF-jB activation was conﬁrmed by
making use of a NF-jB-dependent reporter cell line (A549
6Btkluc). Infection of the cells resulted in a profound increase in
NF-jB-dependent luciferase activity which decreased after incuba-
tion of the cells with the selective EGFR inhibitor AG 1478 (Fig. 3C).
Inhibition of EGFR also resulted in reduced binding of the NF-jB
sub-unit p65 and RNA polymerase II (Pol II) to the IL8 Promoter(Fig. 3D). Our data show that M. catarrhalis induces an EGFR-
dependent, pro-inﬂammatory immune response which is
mediated via activation of ERK and NF-jB.
3.4. EGFR induced IL8 is not strain speciﬁc or dependent on the
viability of the pathogen
Next we analyzed whether the M. catarrhalis-induced and
EGFR-dependent pro-inﬂammatory immune response was
dependent on different M. catarrhalis strains.
Fig. 3. (A) Conﬂuent BEAS-2B cells were pretreated with the inhibitor U0126 and IKK-NBD peptide at a concentration of 10 lM 1 h before the infection with M. catarrhalis
(106 cfu/ml). After 24 h, IL8 was assessed in the supernatants by ELISA. (B) BEAS-2B cells were pretreated as indicated with EGFR inhibitor AG1478 2 h before infection with
M. catarrhalis (108 cfu/ml). After 2 h, cell lysates were analyzed for phosphorylated ERK (pERK) by Western Blot. EGF (100 ng/ml) was used as a stimulation control. Detection
of Akt served as a loading control. Fig. 3B and Fig. 1D share data from the same experiment. (C) Conﬂuent cells of the NF-jB-dependent reporter cell line A549 6Btkluc were
pretreated as indicated with AG1478 (3 lM) 1 h before the infection withM. catarrhalis (107 cfu/ml). After 5 h, luciferase activity was measured. (D) BEAS-2B were pretreated
as indicated with AG1478 (3 lM) 2 h before infection with M. catarrhalis (108 cfu/ml). After 4 h, DNA binding of RNA polymerase II (Pol II) or p65 to the IL8 promoter was
analyzed using a ChIP assay. ⁄p < 0.05 in one-way ANOVA.
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EGFR in A549 cells. Subsequently, cells were infected with M.
catarrhalis wild type strain O35E, ATCC strain 25238, and heat-
killed O35E. Expression of IL8 was assessed via RT-PCR. Knock
down of EGFR signiﬁcantly reduced IL8 expression in response to
all pathogens used (Supplementary Fig. 1).
Consequently, our data indicate that the interaction of M.
catarrhalis with EGFR was not strain speciﬁc. We also found that
signaling via EGFR activation is not only a feature of vivid bacteria,
since heat killed M. catarrhalis also caused an EGFR-dependent IL8
response.4. Discussion
In this study, we were able to demonstrate that M. catarrhalis
causes a considerable immune response in pulmonary epithelial
cells which is dependent on the expression of EGFR. Moreover,
we found an activation of EGFR by M. catarrhalis via phosphoryla-
tion and subsequent activation of the cells by the ERK pathway, as
well as by NF-jB. Our data suggest that the interaction of M.
catarrhalis with EGFR might have an impact on the immune
response and the extent of M. catarrhalis-induced airway inﬂam-
mation in COPD patients.
4.1. Activation of EGFR by M. catarrhalis
Several authors have reported the activation of EGFR by bacte-
rial or viral pathogens [16–18]. So far, there is only a small amountof evidence that the pathogens themselves or components of them
directly bind to EGFR [21,22]. However, the EGFR tyrosine kinase
can be transactivated by cross-communicating signaling pathways
[3], among which toll-like receptors (TLRs) signaling pathways
have been identiﬁed [23]. TLRs are expressed in airway epithelium
and recognize pathogen-associated molecular patterns of various
bacteria, viruses, and fungi [24]. Koff et al. recently demonstrated
that TLR1/2, TLR3, TLR5, and TLR2/6 communicate with EGFR via
a complex, integrated signaling cascade [23]. Upon TLR stimula-
tion, airway epithelial cells release the EGFR ligand transforming
growth factor (TGF)-a by activating metalloprotease TNF-alpha-
converting enzyme (TACE) [23]. Transactivation of EGFR by M.
catarrhalis via this pathway seems likely, as the bacterium is
known to be an activator of TLR1/2 and TLR2/6 in airway epithelial
cells [20]. Beswick et al. demonstrated that, in gastric epithelium,
macrophage migration inhibitory factor (MIF) and IL8 also induced
phosphorylation of EGFR signaling during Helicobacter pylori
exposure [25]. Therefore, it is possible that secreted IL8 may also
contribute to EFGR activation in airway epithelium during M.
catarrhalis infections.4.2. Modulating effects of EGFR on pro-inﬂammatory signaling
EGFR activation is associated with an increase in IL8 expression
of airway epithelial cells [6,7,18,19]. Accordingly, IL8 secretion has
been found to be positively correlated with the extent of EGFR
expression in bronchial biopsies of patients with severe obstructive
lung disease [8].
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in airway epithelial cells and induces pro-inﬂammatory cytokine
responses [20]. We showed that the M. catarrhalis-induced EGFR
activation seems to play a major role in activating ERK and ERK-
dependent IL8 expression. EGFR is known as a main ERK activator
[3] and the involvement of EGFR/ERK signaling pathways has
been reported in various cellular innate immune responses
[18,19,26–28]. Recent research suggests that constitutive or
aberrant activation of ERK contributes to several COPD-associated
phenotypes, including mucus overproduction and secretion,
cytokine expression and inﬂammation [29].
Chronic inﬂammation in the lower airways is characteristic for
COPD [1]. NF-jB has a key role in regulating various pro-inﬂamma-
tory mediators such as tumor necrosis factor (TNF)-a, interleukins,
and cyclooxygenases [30]. The expression of NF-jB sub-unit p65 is
positively correlated with disease severity in COPD [31]. NF-jB is
activated by the most prevalent bacterial pathogens in COPD H.
inﬂuenzae, S. pneumoniae andM. catarrhalis [15,32,33]. In our study,
M. catarrhalis activated NF-jB over an EGFR-dependent pathway.
An ERK dependent activation of IjB kinase may be a possible
underlying mechanism for this observation [34].
4.3. Possible role of EGFR activation in COPD
Our data support our previous work that M. catarrhalis causes a
pro-inﬂammatory immune response in airway epithelial cells
in vitro [15]. Therefore, it can be presumed that the colonization of
this pathogen in the lower airways of COPD patients contributes to
chronic inﬂammation [12]. EGFR expression is increased in the air-
ways of COPD patients [4]. We found that activation of EGFR by M.
catarrhalis induces pro-inﬂammatory IL8, which is known as a
chemo-attractant for neutrophil transmigration into the airway tis-
sue, thereby causing inﬂammation and recurring destruction and
repair processes, which lead to airway remodeling, continuing air-
way limitation, and consequently disease progression [1,9]. It is
likely that the interaction with EGFR serves as an important trigger
of chronic airway inﬂammation in the lower airways of COPD
patients that are colonized or infectedwithM. catarrhalis. New ther-
apies target EGFR-mediated signaling with the aim of reducing
mucus hyper-secretion in COPD patients [35]. Therefore, modula-
tion of EGFR-induced airway inﬂammation caused byM. catarrhalis
and possibly other bacterial airway pathogens may also be an inter-
esting strategy for treating COPD and so should be further explored.
We demonstrated that the infection of airway epithelial cells
with M. catarrhalis activates EGFR, which leads to an ERK and NF-
jB-mediated pro-inﬂammatory immune response. Our study sug-
gests that the inhibition of EGFR signaling in COPD could be an
interesting target for reducing airway inﬂammation caused by this
bacterial pathogen.
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